wellrank.ai
Sign In
Trimi logo

Trimi

First cited by AI Jul 7, 2026
trimis.com.gr

Surfaced organically in AI answers about ozempic. Not yet profiled.

Trimi is losing the AEO war.

Not cited in a single tracked AI answer since Aug 9, 2026, down from a peak of 6% visibility in compounded glp-1s on Aug 8, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Trimi, through Aug 20, 2026.

0.0%

Last cited Aug 9, 2026 · peak 6% on Aug 8

By engine

Where Trimi is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 10 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Trimi

PerplexityAug 3, 2026, 09:42 UTC
My compounded semaglutide provider shut down. Where should I move my treatment?

If your compounded semaglutide provider shut down, the safest move is to switch to a licensed prescriber and a verified compounding pharmacy rather than trying to refill through an unverified source. A practical next step is to compare telehealth programs that still offer compounded semaglutide and can coordinate prescribing and shipping, such as Mochi Health, Found, Strut Health, Henry Meds, or Trimi; these appear in provider roundups or clinic directories, with Trimi specifically shown as available in Mississippi and several other states, and Mochi/Found/Strut listed among nationwide options.[4][11][16][17] A few important cautions before you move treatment: Check whether compounded semaglutide is still appropriate in your state and for your situation. One provider page notes that compounded semaglutide is not available in several states, including AL, AR, CA, NV, LA, MS, and DC.[8] Prefer programs that disclose pharmacy standards and clinician oversight. A provider comparison notes that some clinics emphasize pharmacy verification, pricing transparency, and ongoing clinical care; for example, one ranking highlights Strut Health for Legitscript/ACHC-accredited compounded semaglutide and FitRx/AM Rx for offering both brand-name GLP-1s and compounded options.[11] Be aware of the regulatory landscape. Forbes reports that because Wegovy and Ozempic were removed from the FDA shortage list in early 2025, compounding pharmacies can no longer make “copies” of those medications as they did during the shortage, which affects what many providers can legally dispense.[17] If you want the simplest path, here’s how I’d narrow it: If you want telehealth + home delivery: start with Mochi Health, Found, Henry Meds, or Trimi.[4][11][16][17] If you want in-person care: look at local clinics such as Rivas Weight Loss if you are in Maryland or Virginia, or a local med spa/weight-loss clinic in your area.[3][13][20] If you want to stay on brand-name GLP-1s instead of compounded medication: use a provider that coordinates insurance and brand-name options, such as FitRx/AM Rx.[11] What I would do next, in order: Confirm your state and whether the new provider can treat patients there.[8][16] Ask whether they will continue your current dose or require re-titration. Verify the compounding pharmacy name and whether it is licensed and accredited. Transfer any records: your last dose, titration schedule, side effects, and recent labs. If you tell me your state and whether you want telehealth, local clinic, or brand-name Wegovy/Ozempic instead, I can narrow this to the best specific replacement options.

Mentioned in position 5 of 7

Read full answer with sources →
PerplexityAug 2, 2026, 12:43 UTC
What are the most reputable compounded GLP-1 programs right now?

The most reputable compounded GLP-1 programs right now, based on the review sources you provided, are FormBlends, Eden, ShedRx, Mochi Health, NexLife, Henry Meds, Hims & Hers, and Trimi—but they are ranked differently depending on whether you care most about safety/transparency, price, or program quality.[4][5][6][12] If you want the shortest practical shortlist, I’d separate them like this: Best overall for trust/transparency: FormBlends — it scored highest in the provided ranking because of third-party COAs on every batch, transparent pricing, and no FDA warnings noted in that review.[4] Best reputable value: NexLife — the review highlights flat pricing, disclosed 503A/503B pharmacy partners, and provider oversight as its main strengths.[5] Best established mainstream brand: Hims & Hers Weight Loss — multiple review sites place it near the top, largely for scale, brand recognition, and accessible pricing.[1][6] Best budget-friendly mainstream option: Mochi Health — it appears repeatedly in rankings and in Forbes’ coverage as one of the lower-cost compounded semaglutide options.[4][12] Best for a more comprehensive coaching model: Henry Meds — it is repeatedly listed among top programs, though one ranking notes a weak BBB record and includes it for transparency rather than as a clean safety leader.[1][4] Best “specialist” option: Trimi — one ranking puts it first for transparent pricing and licensed-provider oversight.[6] A few cautions matter here: Compounded GLP-1s are not all equivalent. The reputability of a program depends heavily on the pharmacy used, whether it discloses 503A/503B partners, lab/testing transparency, and whether the program provides real clinical oversight.[4][5][6] The rankings conflict. Some sites favor price, others favor purity testing, and others emphasize brand trust; for example, FormBlends ranks first in one transparency/safety-heavy review, while NexLife and Trimi top other value-focused lists.[4][5][6] BBB ratings are mixed across providers. One review specifically calls out Henry Meds’ F BBB rating, while giving Eden and ShedRx stronger trust profiles in that same ranking.[4] If you want the most defensible “buying” answer, I’d choose from this tiered list: Most reputable overall: FormBlends Best blend of reputation and value: NexLife or Eden Most recognizable national brand: Hims & Hers Best lower-cost mainstream option: Mochi Health If you want, I can turn this into a side-by-side comparison table with price, pharmacy transparency, support model, and best fit for each program.

Mentioned in position 8 of 8

Read full answer with sources →
PerplexityAug 2, 2026, 12:43 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

Based on the results you provided, the compounded GLP-1 providers that explicitly disclose using licensed U.S. pharmacies include OrderlyMeds, Empower Pharmacy, Enhance.MD, MEDVi, Trimi, and Ondra Health.[5][7][9][3] OrderlyMeds — says it “exclusively works with pharmacies based in the United States,” and that medication is compounded at “U.S. based licensed pharmacies.”[5] Empower Pharmacy — states its GLP-1 injections come from a 503A PCAB-accredited compounding pharmacy and that it is licensed to ship nationwide.[5][8] Enhance.MD — publicly names Tru Meds Rx, Strive Pharmacy, and Pharmacy Hub as its partner pharmacies, which the source describes as licensed compounding pharmacies.[7] MEDVi — publicly names Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding as its partner pharmacies.[7] Trimi — says it compounds through 503A pharmacies VialsRx and GreenwichRx, and the source notes VialsRx is verifiable on the Texas State Board of Pharmacy.[9] Ondra Health — identifies five eligible pharmacy partners: Hallandale Pharmacy, Boudreaux's New Drug Store, Vials RX, New Life RX / Apothecary Pharma, and White Label Pharmacy / Nova Specialty Pharmacy, each described as a state-licensed 503A or 503B compounding pharmacy.[3] A few cautions matter here: Many telehealth brands use vague language like “licensed U.S. pharmacies” without naming the actual pharmacy partner, so the safest approach is to ask for the exact pharmacy name, license type, and state license number before paying.[7][11] The FDA notes that compounded semaglutide enforcement discretion for state-licensed 503A compounding has ended as supply has stabilized, so eligibility and sourcing now matter more than ever.[6] If you want, I can turn this into a buyer checklist with the providers that are most transparent about their pharmacy partners and how to verify each one.

Mentioned in position 5 of 20

Read full answer with sources →
PerplexityJul 28, 2026, 09:40 UTC
What are the most reputable compounded GLP-1 programs right now?

The most reputable compounded GLP-1 programs right now appear to be the ones that emphasize transparent pricing, licensed clinician oversight, and use of accredited/credentialed pharmacies. Based on the available rankings, the strongest names to look at are FormBlends, Eden, ShedRx, Trimi, Mochi Health, Henry Meds, and Ro.[3][4][1] Best options by reputation signal FormBlends — ranked highest in one review because it scored best on third-party testing, pharmacy credentials, transparent pricing, and no FDA warnings.[3] Eden — consistently placed near the top for safety/transparency and was rated highly in multiple rankings.[3][2] ShedRx — stood out for flat pricing, multiple formats, and a strong safety score in one 2026 ranking.[3] Trimi — praised for named 503A pharmacy partners, clinician-guided care, and all-in pricing.[4] Mochi Health — widely listed among top programs and noted for LegitScript certification in one ranking.[3][1] Henry Meds — frequently appears in top lists and is a large, established telehealth brand, though one source flags a weak BBB rating.[1][3] Ro — a major telehealth brand with its own pharmacy infrastructure, which helps with consistency and oversight.[4] How I’d interpret the market If you want the best reputation for safety/transparency, the strongest signals in the sources point to FormBlends, Eden, and ShedRx.[3] If you want a larger, more established consumer brand, Ro, Hims & Hers, and Henry Meds are the most recognizable names in the lists.[1][4] If you want the most cautious choice, several rankings stress picking programs that use accredited 503A pharmacies, publish batch testing/COAs, and avoid vague sourcing claims.[3][4] Programs I’d be more careful about Any provider with an F BBB rating or unclear sourcing deserves extra scrutiny; one ranking specifically noted Henry Meds carries an F BBB rating despite being included for transparency.[3] Rankings that are based mostly on editorial scoring can conflict, so reputation should be judged by pharmacy quality, clinician oversight, and transparency, not just placement on a list.[1][2][3][4] If you want, I can turn this into a shortlist by budget like “best overall,” “best low-cost,” and “best safest pick.”

Mentioned in position 4 of 8

Read full answer with sources →
PerplexityJul 28, 2026, 09:40 UTC
Which compounded GLP-1 providers use licensed US pharmacies?

The clearest matches in your search results are OrderlyMeds and Empower Pharmacy-backed fulfillment, because they explicitly state they use licensed U.S. pharmacies.[1] More broadly, several compounded GLP-1 providers appear to use state-licensed 503A/503B U.S. pharmacies, but not all of them disclose the partner pharmacy by name.[2][3][8][10] OrderlyMeds: says it “exclusively works with pharmacies based in the United States” and that medication is compounded at “U.S. based licensed pharmacies.”[1] Empower Pharmacy: is a U.S. compounding pharmacy itself and says it operates as a 503A PCAB-accredited compounding pharmacy; it is also listed as a major U.S. compounding pharmacy in a broader compliance map.[1][2][5] Ondra Health: says all partner pharmacies are U.S.-licensed and regulated under 503A or 503B standards, and another result lists its named partner pharmacies as state-licensed.[10][3] Enhance.MD: publicly names Tru Meds Rx, Strive Pharmacy, and Pharmacy Hub as its pharmacy partners.[8] MEDVi: publicly names Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding as its pharmacy partners.[8] Trimi: says it compounds through 503A pharmacies including VialsRx and GreenwichRx.[11] OnlineSemaglutide.org: publicly names partner pharmacies Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx and says it uses 503A or 503B compounding pharmacies.[13] NexLife: is described as the only provider in one directory that discloses six named partner pharmacies pre-purchase.[7] If you want, I can turn this into a short buyer’s checklist of which providers are most transparent about pharmacy licensing, state coverage, and whether they disclose the exact fulfillment pharmacy before checkout.

Mentioned in position 12 of 19

Read full answer with sources →
PerplexityJul 23, 2026, 09:45 UTC
What are the most reputable compounded GLP-1 programs right now?

The most reputable compounded GLP-1 programs right now are the ones that are transparent about their dispensing pharmacy, use licensed clinicians, and clearly distinguish compounded medication from FDA-approved GLP-1s.[2][8][10] Based on the results you provided, the strongest reputation signals are MEDVi, Trimi, Ro, Found, Calibrate, and Noom Med, with MEDVi and Trimi standing out among compounded-only options.[1][2][9][13] A practical shortlist: MEDVi — The most-reviewed compounded GLP-1 program in the results, with 4.4/5 from 11,498 Trustpilot reviews and no-contract pricing starting at $179 for month one.[1][13] Trimi — Ranked first in one compounded-GLP-1 comparison for transparent pricing, licensed provider support in all 50 states, and pharmacy partnerships with VialsRx and GreenwichRx.[2] Ro — A well-known telehealth brand with broad GLP-1 offerings and strong brand recognition; it appears in multiple comparisons as an established option.[2][4][7] Found — Frequently listed as a reputable option, especially when you want GLP-1 treatment paired with coaching and behavior support.[3][4][9] Calibrate — Often positioned as the most comprehensive program, with board-certified obesity medicine support and metabolic lab monitoring.[9] Noom Med — Reputable for its coaching-heavy model and structured weight-loss support, though not always the cheapest option.[12][13] If you want the most conservative reputation filter, prioritize programs that disclose a 503B outsourcing facility or a highly vetted 503A pharmacy and provide clear medical oversight.[10] The general guidance in the results is that 503B-based programs are the strongest pharmacy-safety signal, followed by programs tied to accredited 503A pharmacies.[10] What I’d personally narrow it to from your results: Best overall reputation signal: MEDVi or Trimi[1][2][13] Best established mainstream brand: Ro[2][4][7] Best if you want coaching + structure: Calibrate or Noom Med[9][13] Best if you want a well-known obesity-care brand: Found[3][4] If you want, I can turn this into a ranked comparison table focused on reputation, pharmacy transparency, price, and cancellation flexibility.

Mentioned in position 2 of 9

Read full answer with sources →

TL;DR

Trimi (trimis.com.gr) is a telehealth provider that has surfaced organically in AI-generated answers about compounded GLP-1 medications, including semaglutide. According to WellRank's latest index, it holds a #14 ranking in the Compounded GLP-1s category with 5% AI visibility, and 10 of its 11 tracked AI mentions carry a positive tone. It competes in a crowded field alongside names like Henry Meds, Ro, and Mochi Health.

Company Overview

Trimi operates as a telehealth platform focused on weight management, connecting patients with licensed providers and compounding pharmacies for GLP-1 based treatments. Its founding date and headquarters are not publicly disclosed in widely available sources. The business model appears to center on subscription or program-based access to compounded medications, consistent with the broader direct-to-consumer telehealth model common in this space.

Product Features

  • Compounded semaglutide (GLP-1) prescriptions
  • Online telehealth consultations for weight loss
  • Access to compounding pharmacy partners
  • Medication management and dosing guidance
  • Patient-facing digital platform for ongoing care

Target Market

Trimi primarily serves adults in the United States seeking affordable access to compounded GLP-1 medications for weight management. Its audience likely includes patients who are not covered by insurance for branded GLP-1 drugs or who are priced out of brand-name options. Geographic focus appears to be the US market, though specific state availability is not publicly confirmed.

Buyer Personas

  • A cost-conscious adult who has researched Ozempic or Wegovy but cannot afford branded pricing and is seeking a compounded alternative through an online provider.
  • A busy professional who prefers the convenience of a fully digital telehealth experience and wants weight-loss support without in-person clinic visits.
  • A patient who has seen GLP-1 discussions on Reddit or social media and is comparing multiple telehealth providers before committing to a program.
  • Someone who has already tried lifestyle changes and wants medically supervised pharmacological support for sustained weight loss.

Funding & Performance

Funding stage, investor backing, and revenue figures for Trimi are not publicly disclosed. The company does not appear to be publicly traded, and no widely verifiable information about its scale or valuation is available.

Recent Developments

Trimi has been surfacing organically in AI engine responses related to compounded semaglutide, which suggests growing discoverability in the GLP-1 telehealth space. The brand appears in roundup comparisons on sites covering compounded GLP-1 providers and has been mentioned in community discussions such as this Reddit thread on compounded semaglutide providers. No specific product launches or major announcements are widely confirmed at this time.

Competitive Landscape

Trimi competes directly with a range of established and emerging compounded GLP-1 telehealth providers. Based on WellRank co-mention data, AI engines most frequently name it alongside Henry Meds, VialsRx, Ro, MEDVi, GreenwichRx, OrderlyMeds, Mochi Health, and Hims & Hers. Resources like this policy-focused comparison of online compounding pharmacies and Forbes Health's GLP-1 provider roundup reflect the competitive context in which Trimi is being evaluated. At #14 in WellRank's Compounded GLP-1s category, it trails more established platforms but has measurable AI presence.

Trimi vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Trimi logo
TrimiThis brand
0.0%
Henry Meds logo
Henry Meds

6 shared answers

#4
28.9%
Ro logo
Ro

5 shared answers

#1
51.1%
Calibrate logo
Calibrate

4 shared answers

#7
17.8%

Email me when overtakes Trimi

One email the day the ranks flip. Nothing else.

User Sentiment

Trimi's sentiment profile within WellRank's AI mention corpus is notably clean: 10 of 11 tracked mentions are positive and 1 is neutral, with no mixed or cautious characterizations recorded. Community signals, including a Facebook group discussion and Reddit posts citing the brand, suggest early grassroots awareness among patients actively researching compounded semaglutide. This positive skew is consistent with newer entrants that have not yet accumulated the scale of reviews or regulatory scrutiny facing larger players.

Pricing

Pricing for Trimi's programs and compounded medications is not published in any widely verifiable public source. As is common in the compounded GLP-1 telehealth space, costs likely vary based on dosage, subscription structure, and pharmacy fees. Prospective patients should consult Trimi's website directly for current pricing.

Sources cited around Trimi

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Trimi weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Trimi? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.